Senesco Technologies Inc. (NYSE:ELOX) shares traded down 1.2% during trading on Tuesday . The stock traded as low as $4.87 and last traded at $4.87, 4,417 shares were traded during trading. A decline of 95% from the average session volume of 96,634 shares. The stock had previously closed at $4.93.
The business’s 50-day moving average price is $4.56 and its two-hundred day moving average price is $6.92.
Senesco Technologies (NYSE:ELOX) last issued its quarterly earnings results on Tuesday, November 5th. The company reported ($0.32) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.39) by $0.07.
Eloxx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Its lead program is ELX-02, which is in Phase I clinical trial, which focuses on the treatment of cystic fibrosis and cystinosis patients with diagnosed nonsense mutations.
Recommended Story: Why are gap-down stocks important?
Receive News & Ratings for Senesco Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senesco Technologies and related companies with MarketBeat.com's FREE daily email newsletter.